Research programme: tuberculosis vaccines - Aeras/China Center for Disease Control and Prevention

Drug Profile

Research programme: tuberculosis vaccines - Aeras/China Center for Disease Control and Prevention

Latest Information Update: 04 Sep 2013

Price : $50

At a glance

  • Originator Aeras; China Center for Disease Control and Prevention
  • Class Tuberculosis vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Tuberculosis

Most Recent Events

  • 29 Aug 2013 Aeras receives 5-year grant from Department for International Development in the United Kingdom for vaccine development in tuberculosis
  • 02 Aug 2013 Early research in Tuberculosis in China (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top